ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Predictive Oncology (AGPU)
Predictive Oncology stock price today, ATLAS forecast and fair value
Technology · Software - Infrastructure · NASDAQ
$8.98▲ +12.39%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
44%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Predictive Oncology in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Predictive Oncology
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Predictive Oncology a 44% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $7.22 and $10.33; in 9 out of 10, between $5.26 and $14.18. Estimated annual volatility is 106%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $140M
- 52-week high
- $13.49
- 52-week low
- $1.41
- Revenue (12 months)
- $3.3M
- Revenue growth (YoY)
- -92.3%
- Gross margin
- 42.0%
- Free cash flow (12 months)
- $-28.4M
- Beta
- 3.49
What this means
ATLAS does not publish a fair value for AGPU right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks AGPU has traded between $1.41 and $13.49. Today it is 33.4% below that high and 537% above its low.
Its beta is 3.49: it tends to move more than the market, both up and down.
About the company
Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services.
Want to see everything about Predictive Oncology?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Predictive Oncology do?
Axe Compute Inc. provides access to graphics processing unit and digital asset treasury strategy. The company operates through two segments: Compute Services and Treasury Management; and Drug Discovery Services.
What is the chance AGPU goes up next month?
44%: somewhat worse than a coin flip. In half of the simulated outcomes, AGPU ends the month between $7.22 and $10.33.
How big is Predictive Oncology and what is its P/E ratio?
Predictive Oncology's market capitalization is $140M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is AGPU?
ATLAS estimates annual volatility at 106%. In a typical month, half of the outcomes end between $7.22 and $10.33.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer